Rare diseases
Investigational molecules
Locations
Back to Czechia6 clinical trials in Breclav, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaCzechiaCzechiaCzechiaCzechiaCzechiaThe busiest research cities in the country
What the registry says about research in the country
Current clinical trials are focusing on evaluating new therapeutic approaches for active psoriatic arthritis (PsA), particularly in patients with varying treatment histories.
These studies aim to assess the effectiveness of novel treatments in reducing PsA symptoms and improving patient outcomes.
Research is centered on investigating innovative compounds including sonelokimab and guselkumab for treating psoriatic arthritis, with special attention to dosing optimization and safety profiles.
The studies examine various treatment protocols to determine optimal therapeutic approaches.
Clinical investigations are exploring patient response patterns across different treatment groups, including those who have not responded well to previous therapies.
These trials aim to expand treatment options for patients with varying degrees of disease severity and treatment history.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
